C. Streicher

Pharmaceutical consultations in oncology: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique – SFPO) guidelines

I. Madelaine, B. Pourroy, Emilie Petit-Jean, 2019, European Journal of Oncology Pharmacy.

Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases.

D. Breilh, E. Lazaro, J. Viallard, 2014, British journal of clinical pharmacology.

Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report

G. Vignaud, C. Streicher, Annick Daulange, 2020, Clinical Drug Investigation.

Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.

T. Suppes, J. Cucchiaro, A. Pikalov, 2016, The American journal of psychiatry.

Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder

J. Calabrese, J. Cucchiaro, A. Pikalov, 2017, European Neuropsychopharmacology.

Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI).

M. Fava, D. Iosifescu, C. Streicher, 2022, The Journal of clinical psychiatry.

Severe rhabdomyolysis induced by possible drug–drug interaction between Ribociclib and Simvastatin

C. Streicher, N. Madranges, L. Vayre, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder

J. Calabrese, J. Cucchiaro, A. Pikalov, 2017, European Neuropsychopharmacology.